Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Blood (2013) 122 (21): 2561.

https://doi.org/10.1182/blood.V122.21.2561.2561

Published: 2013

Journal Articles

Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)

Blood (2013) 122 (21): 520.

https://doi.org/10.1182/blood.V122.21.520.520

Published: 2013

Journal Articles

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Patrice Chevallier, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, Sebastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Marie-Christine Bene, Norbert Ifrah, Herve Dombret

Blood (2012) 119 (11): 2474–2477.

https://doi.org/10.1182/blood-2011-11-390781

Published: 2012

Journal Articles

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Patrice Chevallier, MD, Nelly Robillard, Aude Charbonnier, Emmanuel Raffoux, MD, PhD, Sébastien Maury, Sylvain Carras, Cecile Chabrot, Cecile Fohrer, Marc Bernard, Jean-Sebastien Blade, Anne Etienne, MD, Pascaline Talmant, Jacques Delaunay, Thierry Guillaume, Mohamad Mohty, Norbert Ifrah, Herve Dombret

Blood (2011) 118 (21): 1525.

https://doi.org/10.1182/blood.V118.21.1525.1525

Published: 2011

Journal Articles

Morphology, Cytogenetics and Survival In myelodysplasia with Del(20q) or Ider(20q): a Multicentric Study

François Mullier, Sylvie Daliphard, Richard Garand, Mélanie Dekeyser, Yvan Cornet, Isabelle Luquet, MD, PhD, Pascaline Talmant, Steven Richebourg, Mauricette Jamar, Jean-Michel Dogné, Christian Chatelain, Lucienne Michaux, Bernard Chatelain

Blood (2010) 116 (21): 2942.

https://doi.org/10.1182/blood.V116.21.2942.2942

Published: 2010

Journal Articles

Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

Blood (2010) 116 (21): 582.

https://doi.org/10.1182/blood.V116.21.582.582

Published: 2010

Journal Articles

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Blood (2010) 115 (15): 3089–3097.

https://doi.org/10.1182/blood-2009-07-234229

Published: 2010

Includes: Supplemental data

Journal Articles

Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation

Marina Bousquet, Cathy Quelen, Roberto Rosati, Véronique Mansat-De Mas, Christian Bastard, Eric Lippert, Pascaline Talmant, Marina Lafage-Pochitaloff, Dominique Leroux, Carine Gervais, Franck Viguie, Jean-Luc Lai, Christine Terre, Georges Delsol, Nicole Dastugue, Cristina Mecucci, Pierre Brousset

Blood (2008) 112 (11): 4148.

https://doi.org/10.1182/blood.V112.11.4148.4148

Published: 2008

Journal Articles

CALM-AF10 Positive Acute Myeloid Leukemias: A French Cohort of 18 Patients.

Blood (2008) 112 (11): 1496.

https://doi.org/10.1182/blood.V112.11.1496.1496

Published: 2008

Journal Articles

Prognostic Value of Cytogenetics in Patients with Acute Myeloid Leukemia Aged More Than 60 Years at Diagnosis: Identification of Subgroups Taking Benefit from Intensive Chemotherapy. Results from a Large Single Center Retrospective Study.

Nicolas Blin, MD, Pascaline Talmant, MD, Richard Garand, MD, Francoise Accard, MD, Philippe Moreau, MD, Jean-Luc Harousseau, MD, Herve Avet-Loiseau, MD, PhD

Blood (2007) 110 (11): 3503.

https://doi.org/10.1182/blood.V110.11.3503.3503

Published: 2007

Journal Articles

Efficacy of Imatinib-Based Therapy in a Patient with Resistant NUP214-ABL1 T-Cell Acute Lymphoblastic Leukemia.

Jacques Delaunay, MD, Raouf Ben Abdelali, MD, Cyrille Touzeau, MD, Patrice Chevallier, MD, Guillaume Thierry, MD, Steven Le Gouill, MD, PhD, Sameh Ayari, MD, Jean-Luc Harousseau, MD, Elisabeth Macintyre, MD, PhD, Herve Avet Loiseau, MD, PhD, Herve Dombret, MD, Pascaline Talmant, MD

Blood (2007) 110 (11): 4329.

https://doi.org/10.1182/blood.V110.11.4329.4329

Published: 2007

Journal Articles

Leukemic blasts in transformed JAK2-V617F –positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Alexandre Theocharides, Marjorie Boissinot, François Girodon, Richard Garand, Soon-Siong Teo, Eric Lippert, Pascaline Talmant, Andre Tichelli, Sylvie Hermouet, Radek C. Skoda

Blood (2007) 110 (1): 375–379.

https://doi.org/10.1182/blood-2006-12-062125

Published: 2007

Includes: Supplemental data

Journal Articles

Clonal Chromosomal Abnormalities in Philadelphia Negative Cells during Dasatinib Treatment in Five Patients with Chronic Myeloid Leukemia.

Viviane Dubruille, Pascaline Talmant, Herve Avet Loiseau, Philippe Moreau, Jean-Luc Harousseau

Blood (2006) 108 (11): 4823.

https://doi.org/10.1182/blood.V108.11.4823.4823

Published: 2006

Journal Articles

The t(14;19)(q32;q13) Translocation in B Lymphoproliferative Disorders: A Continuum from Chronic Lymphocytic Leukemia (CLL) to Marginal Zone Lymphoma (MZL)?.

Florence Nguyen-Khac, MD, PhD, Elise Chapiro, MD, Isabelle Radford-Weiss, MD, Christian Bastard, MD,PhD, Leroux Dominique, MD,PhD, Evelyne Callet-Bauchu, MD,PhD, Pascaline Talmant, MD, Isabelle Luquet, MD,PhD, Mozziconacci Marie-Joelle, MD,PhD, Lessard Michel, MD,PhD, Raynaud D. Sophie, MD,PhD, Frederic Davi, MD,PhD, Helene Merle-Beral, MD,PhD, Francoise Berger, MD,PhD, Roland Berger, MD,PhD

Blood (2006) 108 (11): 4944.

https://doi.org/10.1182/blood.V108.11.4944.4944

Published: 2006

Journal Articles

High Grade Non-Hodgkin’s Lymphoma with Tandem t(14;18) and c-MYC Rearrangement Is a Pathological Lymphoma Entity with Aggressive Clinical Presentation and Very Poor Prognosis.

Cyrille Touzeau, Pascaline Talmant, Anne Moreau, Richard Garand, Herve Avet-Loiseau, Nadine Juge-Morineau, Thomas Gastinne, Philippe Moreau, Jean-Luc Harousseau, Steven Le Gouill

Blood (2006) 108 (11): 2045.

https://doi.org/10.1182/blood.V108.11.2045.2045

Published: 2006

Journal Articles

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

Blood (2003) 101 (4): 1277–1283.

https://doi.org/10.1182/blood-2002-05-1474

Published: 2003

Journal Articles

Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH)

Nicole Dastugue, Marina Lafage-Pochitaloff, Marie-Pierre Pagès, Isabelle Radford, Christian Bastard, Pascaline Talmant, Marie Joelle Mozziconacci, Claude Léonard, Christelle Bilhou-Nabéra, Christine Cabrol, Anne-Marie Capodano, Pascale Cornillet-Lefebvre, Michel Lessard, Francine Mugneret, Christine Pérot, Sylvie Taviaux, Odile Fenneteaux, Eliane Duchayne, Roland Berger

Blood (2002) 100 (2): 618–626.

https://doi.org/10.1182/blood-2001-12-0241

Published: 2002

Journal Articles

CD4 + , CD56 + DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique

Dominique Leroux, Francine Mugneret, Mary Callanan, Isabelle Radford-Weiss, Nicole Dastugue, Jean Feuillard, Franseza Le Mée, Ghislaine Plessis, Pascaline Talmant, Nathalie Gachard, Françoise Uettwiller, Marie-Pierre Pages, Marie-Joëlle Mozziconacci, Virginie Eclache, Catherine Sibille, Hervé Avet-Loiseau, Marina Lafage-Pochitaloff

Blood (2002) 99 (11): 4154–4159.

https://doi.org/10.1182/blood.V99.11.4154

Published: 2002

Journal Articles

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique

Hervé Avet-Loiseau, Axelle Daviet, Christophe Brigaudeau, Evelyne Callet-Bauchu, Christine Terré, Marina Lafage-Pochitaloff, François Désangles, Sylvie Ramond, Pascaline Talmant, Régis Bataille

Blood (2001) 97 (3): 822–825.

https://doi.org/10.1182/blood.V97.3.822

Published: 2001

Journal Articles

Fusion of a Novel Gene, BTL , to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)

Jan Cools, Chrystèle Bilhou-Nabera, Iwona Wlodarska, Christine Cabrol, Pascaline Talmant, Philippe Bernard, Anne Hagemeijer, Peter Marynen

Blood (1999) 94 (5): 1820–1824.

https://doi.org/10.1182/blood.V94.5.1820

Published: 1999

NARROW

NOTCH1 Mutations Are Associated With The 14q Deletion In Chronic Lymphocytic Leukemia (CLL) and Small Lymphocytic Lymphoma (SLL)

Backtracking Subclonal Mutations Of TP53 In Myelodysplasia (MDS) With Del(5q) With Next-Generation Sequencing (NGS)

Trastuzumab for treatment of refractory/relapsed HER2-positive adult B-ALL: results of a phase 2 GRAALL study

Trastuzumab (Herceptin®) for Treatment of Refractory/Relapsed HER2 Positive Adult B-ALL: Results of a Phase II GRAALL Study

Morphology, Cytogenetics and Survival In myelodysplasia with Del(20q) or Ider(20q): a Multicentric Study

Specific Chromosomal IG Translocations Have Different Prognosis In Chronic Lymphocytic Leukemia

Wide diversity of PAX5 alterations in B-ALL: a Groupe Francophone de Cytogénétique Hématologique study

Myeloid Cell Differentiation Arrest by Mir-125b-1 in Myelodysplasic Syndrome and Acute Myeloid Leukemia with the T(2;11)(p21;q23) Translocation

CALM-AF10 Positive Acute Myeloid Leukemias: A French Cohort of 18 Patients.

Prognostic Value of Cytogenetics in Patients with Acute Myeloid Leukemia Aged More Than 60 Years at Diagnosis: Identification of Subgroups Taking Benefit from Intensive Chemotherapy. Results from a Large Single Center Retrospective Study.

Efficacy of Imatinib-Based Therapy in a Patient with Resistant NUP214-ABL1 T-Cell Acute Lymphoblastic Leukemia.

Leukemic blasts in transformed JAK2-V617F –positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Clonal Chromosomal Abnormalities in Philadelphia Negative Cells during Dasatinib Treatment in Five Patients with Chronic Myeloid Leukemia.

The t(14;19)(q32;q13) Translocation in B Lymphoproliferative Disorders: A Continuum from Chronic Lymphocytic Leukemia (CLL) to Marginal Zone Lymphoma (MZL)?.

High Grade Non-Hodgkin’s Lymphoma with Tandem t(14;18) and c-MYC Rearrangement Is a Pathological Lymphoma Entity with Aggressive Clinical Presentation and Very Poor Prognosis.

M0 AML, clinical and biologic features of the disease, including AML1 gene mutations: a report of 59 cases by the Groupe Français d'Hématologie Cellulaire (GFHC) and the Groupe Français de Cytogénétique Hématologique (GFCH)

Cytogenetic profile of childhood and adult megakaryoblastic leukemia (M7): a study of the Groupe Français de Cytogénétique Hématologique (GFCH)

CD4 + , CD56 + DC2 acute leukemia is characterized by recurrent clonal chromosomal changes affecting 6 major targets: a study of 21 cases by the Groupe Français de Cytogénétique Hématologique

Cytogenetic, interphase, and multicolor fluorescence in situ hybridization analyses in primary plasma cell leukemia: a study of 40 patients at diagnosis, on behalf of the Intergroupe Francophone du Myélome and the Groupe Français de Cytogénétique Hématologique

Fusion of a Novel Gene, BTL , to ETV6 in Acute Myeloid Leukemias With a t(4;12)(q11-q12;p13)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only